Legend Biotech Corp Number Of Share Options Exercised In Share-based Payment Arrangement
Legend Biotech Corp (LEGN) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 776.00 thousand shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2026-03-10
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month as first filed |
|---|---|---|
| 2025-12-31 | 776.00K shares 20-F · filed 2026-03-10 | |
| 2024-12-31 | 1.60M shares 20-F · filed 2026-03-10 | |
| 2023-12-31 | 2.46M shares 20-F · filed 2026-03-10 | |
| 2022-12-31 | 2.04M shares 20-F · filed 2025-03-11 | |
| 2021-12-31 | 4.06M shares 20-F · filed 2024-03-19 | 4.06K shares 20-F · filed 2022-03-31 |
| 2020-12-31 | 1.68M shares 20-F · filed 2023-03-30 | 1.68K shares 20-F · filed 2021-04-02 |